{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 174 - Bruce Leuchter - President & CEO Neurvati","slug":"episode-174-bruce-leuchter-president-ceo-neurvati","published_at":"2026-05-18T16:57:55+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-174-bruce-leuchter-president-ceo-neurvati","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-174---Bruce-Leuchter---President--CEO-Neurvati-e3ji04c","audio_url":"https://anchor.fm/s/f0076084/podcast/play/120176204/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-18%2F424402608-44100-2-9cdd6df7297d7.mp3","summary":"In this episode of The BioHub Podcast, Max sits down with Bruce Leuchter, co-founder and CEO of Neurvati Neurosciences. Bruce’s career spans clinical neuroscience, psychiatry, investment banking, and biotech company building — giving him a uniquely broad perspective on the future of CNS drug development. Neurvati, a Blackstone Life Sciences portfolio company, is focused on identifying and advancing high-potential therapies for neurological and psychiatric disorders. In this conversation, we discuss the evolving neuroscience landscape, how to choose the right assets and modalities, the differences between public and private markets in neuro, and why building the right team is so critical in biotech. A thoughtful conversation about one of the most challenging — and exciting — areas in medicine.","meta_description":"In this episode of The BioHub Podcast, Max sits down with Bruce Leuchter, co-founder and CEO of Neurvati Neurosciences. Bruce’s career spans clinical neur…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2018,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-174-bruce-leuchter-president-ceo-neurvati/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-174-bruce-leuchter-president-ceo-neurvati.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}